NQO1 alleviates renal fibrosis by inhibiting the TLR4/NF-κB and TGF-β/Smad signaling pathways in diabetic nephropathy
Cellular Signalling · 2023-08 · 108 · 110712
DOI: 10.1016/j.cellsig.2023.110712 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cellular Signalling, 2023-08. Verfasst von Duojun Qiu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Hebei Medical University, Shijiazhuang, China; Department of Pathology, The First Hospital of Hebei Medical University, Shij…. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Diabetic Nephropathies, NAD(P)H Dehydrogenase (Quinone), Signal Transduction. Die Arbeit wurde bisher 84-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Hebei Province Graduate Innovation Funding Project.
Abstract (Originalsprache)
OBJECTIVE: Diabetic nephropathy (DN) is one of the main complications of diabetes, and inflammation and fibrosis play an important role in its progression. NAD(P)H: quinone oxidoreductase 1 (NQO1) protects cells from oxidative stress and damage caused by toxic quinones. In the present study, we aimed to investigate the protective effects of NQO1 against diabetes-induced renal inflammation and fibrosis and the underlying mechanisms. METHODS: In vivo, the kidneys of type 2 diabetes model db/db mice were infected with adeno-associated virus vectors to induce NQO1 overexpression. In vitro, human renal tubular epithelial (HK-2) cells transfected with NQO1 pcDNA3.1(+) were cultured under high-glucose (HG) conditions. Gene and protein expression was assessed by quantitative real-time PCR, Western blotting, immunofluorescence, and immunohistochemical staining. Mitochondrial reactive oxygen species (ROS) were detected with MitoSOX Red. RESULT: Our study revealed that the expression of NQO1 was markedly downregulated and that Toll-like receptor (TLR)4 and TGF-β1 expression was upregulated in vivo and in vitro under diabetic conditions. Overexpression of NQO1 suppressed proinflammatory cytokine (IL-6, TNF-α, MCP-1) secretion, extracellular matrix (ECM) (collagen IV, fibronectin) accumulation and epithelial-mesenchymal transition (EMT) (α-SMA, E-cadherin) in the db/db mouse kidneys and HG-cultured HK-2 cells. Furthermore, NQO1 overexpression ameliorated HG-induced TLR4/NF-κB and TGF-β/Smad pathways activation. Mechanistic studies demonstrated that a TLR4 inhibitor (TAK-242) suppressed the TLR4/NF-κB signaling pathway, proinflammatory cytokine secretion, EMT and ECM-related protein expression in HG-exposed HK-2 cells. In addition, we found that the antioxidants N-acetylcysteine (NAC) and tempol increased the expression of NQO1 and decreased the expression of TLR4, TGF-β1, Nox1, and Nox4 and ROS production in HK-2 cells cultured under HG conditions. CONCLUSIONS: These data suggest that NQO1 alleviates diabetes-induced renal inflammation and fibrosis by regulating the TLR4/NF-κB and TGF-β/Smad signaling pathways.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Hebei Medical University, Shijiazhuang, China; Department of Pathology, The First Hospital of Hebei Medical University, Shijiazhuang, China.
- Department of Pathology, Hebei Medical University, Shijiazhuang, China.
- Department of Pathology, The First Hospital of Hebei Medical University, Shijiazhuang, China.
- Department of Pathology, Hebei Medical University, Shijiazhuang, China; Hebei Key Laboratory of Kidney Diseases, Shijiazhuang, China. Electronic address: duanhuijun999@163.com.
- Department of Pathology, Hebei Medical University, Shijiazhuang, China; Hebei Key Laboratory of Kidney Diseases, Shijiazhuang, China. Electronic address: yonghongshi@126.com.
Förderung
- National Natural Science Foundation of China
- Hebei Province Graduate Innovation Funding Project
Zitieren
APA
Qiu, D., Song, S., Chen, N., Bian, Y., Yuan, C., Zhang, W., Duan, H., & Shi, Y. (2023). NQO1 alleviates renal fibrosis by inhibiting the TLR4/NF-κB and TGF-β/Smad signaling pathways in diabetic nephropathy. Cellular Signalling, 108, 110712. https://doi.org/10.1016/j.cellsig.2023.110712
Vancouver
Qiu D, Song S, Chen N, Bian Y, Yuan C, Zhang W, et al. NQO1 alleviates renal fibrosis by inhibiting the TLR4/NF-κB and TGF-β/Smad signaling pathways in diabetic nephropathy. Cellular Signalling. 2023;108:110712. doi:10.1016/j.cellsig.2023.110712
BibTeX
@article{Qiu2023,
author = {Qiu, Duojun and Song, Shan and Chen, Ning and Bian, Yawei and Yuan, Chen and Zhang, Wei and Duan, Huijun and Shi, Yonghong},
title = {NQO1 alleviates renal fibrosis by inhibiting the TLR4/NF-κB and TGF-β/Smad signaling pathways in diabetic nephropathy},
journal = {Cellular Signalling},
year = {2023},
volume = {108},
pages = {110712},
doi = {10.1016/j.cellsig.2023.110712}
}
EUVIMED